Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Moderately-to-Severely Active Rheumatoid Arthritis
.
Show all posts
Showing posts with label
Moderately-to-Severely Active Rheumatoid Arthritis
.
Show all posts
Wednesday, September 5, 2018
FDA Approves Olumiant (baricitinib) 2 mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis
›
Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) h...
›
Home
View web version
